Medicine and Dentistry
Prostate Cancer
100%
Radiation Therapy
72%
Neoplasm
43%
Hypoxia
30%
Radiosensitivity
20%
Malignant Neoplasm
19%
DNA Repair
15%
Diseases
15%
Biological Marker
14%
Biochemical Recurrence
14%
Image-Guided Radiation Therapy
13%
Cancer Cell
12%
Metastatic Carcinoma
12%
Prognostic Factor
10%
DNA Damage
10%
Tumor Hypoxia
9%
Bladder Cancer
9%
Prostatectomy
8%
Protein P53
8%
Biopsy
8%
Double Stranded DNA
7%
Tumor Cell
7%
Gleason Score
7%
Therapeutic Window
7%
Hormone Therapy
7%
External Beam Radiotherapy
7%
Prostate Tumor
7%
Homologous Recombination
7%
Xenograft
6%
Intensity Modulated Radiation Therapy
6%
Recurrent Disease
6%
PARP Inhibitor
6%
Radiation Response
6%
Genomic Instability
6%
Intraductal Carcinoma
5%
Cystectomy
5%
Radiosensitization
5%
In Vitro
5%
Biochemistry, Genetics and Molecular Biology
Radiosensitivity
20%
Cancer Cell
19%
DNA Damage
18%
P53
17%
DNA Repair
14%
Genome Instability
13%
Tumor Hypoxia
12%
Homologous Recombination
12%
Germline
10%
Germ Cell
10%
BRCA2
8%
Single-Nucleotide Polymorphism
7%
Carcinogenesis
7%
Mouse
6%
Gleason Score
6%
DNA Damage Response
5%
Fibroblast
5%
BRCA1
5%
Cell Cycle
5%
RAD51
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
48%
Neoplasm
24%
Ionizing Radiation
11%
Hypoxia
11%
Disease
10%
Malignant Neoplasm
9%
Double Stranded DNA
7%
Biological Marker
6%
Protein P53
6%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
5%
Chemotherapy
5%